Immunoprecise Antibodies Ltd Asset Resilience Ratio

Latest as of January 2017: 3.43%

Immunoprecise Antibodies Ltd asset resilience ratio. Immunoprecise Antibodies Ltd (IPA) has an Asset Resilience Ratio of 3.43% as of January 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Immunoprecise Antibodies Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$156.92K

Cash + Short-term Investments

Total Assets

$4.58 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Immunoprecise Antibodies Ltd (1997–2020)

Asset resilience ratio of Immunoprecise Antibodies Ltd from 1997 to 2020. This chart shows how Immunoprecise Antibodies Ltd's Asset Resilience Ratio has changed over time. Read debt load of Immunoprecise Antibodies Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Immunoprecise Antibodies Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Immunoprecise Antibodies Ltd balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$156.92K	3.43%
Total Liquid Assets	$156.92K	3.43%

Asset Resilience Insights

Limited Liquidity: Immunoprecise Antibodies Ltd maintains only 3.43% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Immunoprecise Antibodies Ltd Industry Peers by Asset Resilience Ratio

Compare Immunoprecise Antibodies Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Immunoprecise Antibodies Ltd Asset Resilience Ratio by Year (1997–2020)

Immunoprecise Antibodies Ltd asset resilience ratio by year from 1997 to 2020. The table below shows the annual Asset Resilience Ratio data for Immunoprecise Antibodies Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-04-30	0.00%	$104.00	$27.26 Million	--
2017-04-30	0.00%	$0.00	$3.93 Million	--
2016-04-30	15.51%	$214.14K	$1.38 Million	+15.04pp
2010-04-30	0.47%	$26.00K	$5.53 Million	+0.00pp
2009-04-30	0.47%	$32.50K	$6.93 Million	-4.44pp
2008-04-30	4.91%	$253.25K	$5.16 Million	+4.37pp
2007-04-30	0.54%	$31.34K	$5.84 Million	+0.31pp
2006-04-30	0.22%	$9.00K	$4.05 Million	-0.59pp
2001-04-30	0.81%	$9.40K	$1.16 Million	+0.24pp
1999-04-30	0.57%	$9.40K	$1.66 Million	-6.17pp
1998-04-30	6.73%	$197.32K	$2.93 Million	-50.56pp
1997-04-30	57.30%	$2.22 Million	$3.88 Million	--

pp = percentage points

About Immunoprecise Antibodies Ltd

NASDAQ:IPA USA Biotechnology

Market Cap

$95.54 Million

Market Cap Rank

#19176 Global

#4435 in USA

Share Price

$2.07

Change (1 day)

+0.00%

52-Week Range

$2.07 - $2.07

All Time High

$18.70